phenyl acetate has been researched along with Diffuse Parenchymal Lung Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Álvaro-Vegue, C; Carrasco-Muñoz, CG; García-Villa, A; Gomis-Goti, C; Villalba-Cuesta, PL | 1 |
| Jiang, Z; Liu, X; Lyu, L | 1 |
| Balfour-Lynn, IM; Turnbull, A | 1 |
| Fireman, E; Greif, J; Mann, A; Schwartz, Y | 1 |
| Chohnabayashi, N; Nishimura, N; Sugiura, R | 1 |
2 review(s) available for phenyl acetate and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Recent advances in paediatric respiratory medicine.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bronchopulmonary Dysplasia; Ciliary Motility Disorders; Cyclopropanes; Humans; Lung Diseases, Interstitial; Medication Adherence; Pediatrics; Pulmonary Medicine; Quinolines; Saline Solution, Hypertonic; Sleep Apnea, Obstructive; Sulfides | 2016 |
[Adverse effects of leukotriene-antagonists].
Topics: Acetates; Anaphylaxis; Chemical and Drug Induced Liver Injury; Chromones; Cyclopropanes; Drug Interactions; Enzyme Inhibitors; Hematologic Diseases; Humans; Indoles; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases, Interstitial; Membrane Proteins; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2007 |
3 other study(ies) available for phenyl acetate and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Interstitial pneumonitis associated with leuprorelin acetate for a prostate cancer: A case report.
Topics: Acetates; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Humans; Leuprolide; Lung Diseases, Interstitial; Male; Prostatic Neoplasms | 2022 |
[A case of neuroendocrine cell hyperplasia of infancy (NEHI)].
Topics: Acetates; Cyclopropanes; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Hyperplasia; Infant; Lung; Lung Diseases, Interstitial; Methylprednisolone; Neuroendocrine Cells; Quinolines; Sulfides; Tomography, X-Ray Computed | 2014 |
Effect of montelukast, a cysteinyl receptor antagonist, on myofibroblasts in interstitial lung disease.
Topics: Acetates; Actins; Adult; Cell Proliferation; Cells, Cultured; Cyclopropanes; Female; Fibroblasts; Fibrosis; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Quinolines; RNA, Messenger; Sarcoidosis; Sulfides; Transforming Growth Factor beta | 2004 |